首页> 外国专利> Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans

Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans

机译:用于人类阿尔茨海默氏病和唐氏综合症症状前检测和治疗靶向的药物

摘要

Agents and methods for the diagnosis and therapy of Alzheimer's disease and the related condition Down syndrome are disclosed. Such agents include four genes located within the region of human chromosome 21 occupied by the APP gene, which are exclusively expressed in Alzheimer's disease or Down syndrome, respectively, the proteins encoded and expressed by these genes, the nucleic acid molecules influencing their expression, and endogenous antibodies produced in humans with Alzheimer's disease and Down syndrome against the above proteins. Also disclosed are antibodies and nucleotides to detect the presence of the proteins and nucleic acids in humans.
机译:公开了用于阿尔茨海默氏病和相关病症唐氏综合症的诊断和治疗的药剂和方法。这些试剂包括位于APP基因所占据的人类21号染色体区域内的四个基因,分别在阿尔茨海默氏病或​​唐氏综合症中专门表达,这些基因编码和表达的蛋白质,影响它们表达的核酸分子,以及在患有阿尔茨海默氏病和唐氏综合症的人类中针对上述蛋白质产生的内源性抗体。还公开了用于检测人中蛋白质和核酸的存在的抗体和核苷酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号